Safety of stem cell mobilization in donors with sickle cell trait

Bone Marrow Transplant. 2015 Feb;50(2):310-1. doi: 10.1038/bmt.2014.252. Epub 2014 Nov 3.

Authors

M Al-Khabori¹, F Al-Ghafri¹, S Al-Kindi¹, A Z Al-Riyami¹, K Al-Farsi¹, M Al-Huneini¹, D Dennison¹, A Al-Rawas², H Khan¹, S Daar¹

Affiliations

¹ Department of Hematology, Sultan Qaboos University Hospital, Muscat, Oman.
² Department of Child Health, Sultan Qaboos University Hospital, Muscat, Oman.

PMID: 25365063
DOI: 10.1038/bmt.2014.252

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Adult
Child
Female
Filgrastim
Granulocyte Colony-Stimulating Factor / administration & dosage*
Granulocyte Colony-Stimulating Factor / adverse effects
Hematopoietic Stem Cell Mobilization / methods*
Humans
Male
Recombinant Proteins / administration & dosage
Recombinant Proteins / adverse effects
Retrospective Studies
Safety*
Sickle Cell Trait*

Substances

Recombinant Proteins
Granulocyte Colony-Stimulating Factor
Filgrastim